KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Inventory (2016 - 2025)

Tenet Healthcare's Inventory history spans 17 years, with the latest figure at $348.0 million for Q4 2025.

  • For Q4 2025, Inventory rose 0.58% year-over-year to $348.0 million; the TTM value through Dec 2025 reached $348.0 million, up 0.58%, while the annual FY2025 figure was $348.0 million, 0.58% up from the prior year.
  • Inventory for Q4 2025 was $348.0 million at Tenet Healthcare, up from $346.0 million in the prior quarter.
  • Across five years, Inventory topped out at $413.0 million in Q3 2023 and bottomed at $338.0 million in Q2 2025.
  • The 5-year median for Inventory is $383.0 million (2021), against an average of $378.0 million.
  • The largest annual shift saw Inventory grew 13.58% in 2021 before it fell 15.82% in 2024.
  • A 5-year view of Inventory shows it stood at $384.0 million in 2021, then increased by 5.47% to $405.0 million in 2022, then grew by 1.48% to $411.0 million in 2023, then decreased by 15.82% to $346.0 million in 2024, then increased by 0.58% to $348.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Inventory are $348.0 million (Q4 2025), $346.0 million (Q3 2025), and $338.0 million (Q2 2025).